Adelina Qerimi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Adelina Qerimi has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Christoph A. Schatz
Bayer AG, Pharmaceuticals Berlin Germany
2 shared publications - Johannes Haybaeck
Department of Pathology, Saint Vincent Hospital Zams, 6511 Zams, Austria
2 shared publications - Doris Wilflingseder
Ignaz Semmelweis Institute, Interuniversity Institute for Infection Research, Vetmeduni, Vienna, Austria
1 shared publication - Dorothee von Laer
Institute of Virology, Medical University of Innsbruck, 6020 Innsbruck, Austria
1 shared publication - Eliott Lafon
Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Schöpfstraße 41, 6020 Innsbruck, Austria
1 shared publication - Florian Prüller
Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria
1 shared publication
Latest Publications
- Open Access
- 15 April 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (4) , 798
Machine Learning to Identify Critical Biomarker Profiles in New SARS-CoV-2 Variants
The global dissemination of SARS-CoV-2 resulted in the emergence of several variants, including Alpha, Alpha + E484K, Beta, and Omicron. Our research integrated the study of eukaryotic translation factors and fundamental components in general protein synthesis with the analysis of SARS-CoV-2 variants and vaccination status. Utilizing statistical methods, we successfully differentiated between variants in infected individuals and, to a lesser extent, between vaccinated and non-vaccinated infected individuals, relying on the expression profiles of translation factors. Additionally, our investigation identified common causal relationships among the translation factors, shedding light on the interplay between SARS-CoV-2 variants and the host’s translation machinery.
- 15 April 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (4) , 798
Open AccessMachine Learning to Identify Critical Biomarker Profiles in New SARS-CoV-2 Variants
The global dissemination of SARS-CoV-2 resulted in the emergence of several variants, including Alpha, Alpha + E484K, Beta, and Omicron. Our research integrated the study of eukaryotic translation factors and fundamental components in general protein synthesis with the analysis of SARS-CoV-2 variants and vaccination status. Utilizing statistical methods, we successfully differentiated between variants in infected individuals and, to a lesser extent, between vaccinated and non-vaccinated infected individuals, relying on the expression profiles of translation factors. Additionally, our investigation identified common causal relationships among the translation factors, shedding light on the interplay between SARS-CoV-2 variants and the host’s translation machinery.
- 21 November 2023
- Published by Springer Nature in Die Pathologie
- Vol. 44 (S3) , 229-231
Digital pathology in Austria
Zusammenfassung Die Situation zur digitalen Pathologie in Österreich ist im internationalen Vergleich überschaubar. Exemplarisch werden das Konsortium EMPAIA, die privat-öffentliche Partnerschaft Bigpicture, die Österreichische Gesellschaft für Klinische Pathologie und Molekularpathologie (ÖGPath), das Unternehmen TissueGnostics und die Österreichische Plattform für Personalisierte Medizin (ÖPPM) genannt, die in Österreich aktiv sind.
- 21 November 2023
- Published by Springer Nature in Die Pathologie
- Vol. 44 (S3) , 229-231
Digital pathology in Austria
Zusammenfassung Die Situation zur digitalen Pathologie in Österreich ist im internationalen Vergleich überschaubar. Exemplarisch werden das Konsortium EMPAIA, die privat-öffentliche Partnerschaft Bigpicture, die Österreichische Gesellschaft für Klinische Pathologie und Molekularpathologie (ÖGPath), das Unternehmen TissueGnostics und die Österreichische Plattform für Personalisierte Medizin (ÖPPM) genannt, die in Österreich aktiv sind.